Eyebright Medical Technology (Beijing) Co., Ltd. (688050) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Eyebright Medical Technology (Beijing) Co., Ltd.

Why is Eyebright Medical Technology (Beijing) Co., Ltd. ?

Negative results in Mar 25

INTEREST(Q) At CNY 6.86 MM has Grown at 19.17%
INTEREST COVERAGE RATIO(Q) Lowest at 1,378.97
RAW MATERIAL COST(Y) Grown by 5.07% (YoY)

With ROE of 14.14%, it has a expensive valuation with a 4.92 Price to Book Value

Over the past year, while the stock has generated a return of -34.12%, its profits have risen by 20.2% ; the PEG ratio of the company is 1.7

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -34.12% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Eyebright Medical Technology (Beijing) Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Eyebright Medical Technology (Beijing) Co., Ltd.

-34.12%

-0.50

37.76%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

49.20%

EBIT Growth (5y)

49.05%

EBIT to Interest (avg)

83.12

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

0.40

Tax Ratio

9.26%

Dividend Payout Ratio

17.06%

Pledged Shares

Institutional Holding

ROCE (avg)

14.21%

ROE (avg)

12.24%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.92

EV to EBIT

31.69

EV to EBITDA

23.01

EV to Capital Employed

5.29

EV to Sales

9.04

PEG Ratio

1.72

Dividend Yield

0.18%

ROCE (Latest)

16.68%

ROE (Latest)

14.14%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 377.02 MM

NET SALES(9M)

At CNY 1,068.79 MM has Grown at 26.5%

-17What is not working for the Company

INTEREST(Q)

At CNY 6.86 MM has Grown at 19.17%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,378.97

RAW MATERIAL COST(Y)

Grown by 5.07% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.25%

OPERATING PROFIT(Q)

Lowest at CNY 94.65 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 26.86 %

Here's what is working for Eyebright Medical Technology (Beijing) Co., Ltd.

Net Sales

At CNY 1,068.79 MM has Grown at 26.5%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Cash Flow

Highest at CNY 377.02 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Here's what is not working for Eyebright Medical Technology (Beijing) Co., Ltd.

Interest

At CNY 6.86 MM has Grown at 19.17%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 1,378.97

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest

Highest at CNY 6.86 MM

in the last five periods and Increased by 19.17% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit

Lowest at CNY 94.65 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 26.86 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debtors Turnover Ratio

Lowest at 4.25%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 5.07% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income

Highest at CNY 0.12 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income